Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juan Carlos Serna-Ojeda is active.

Publication


Featured researches published by Juan Carlos Serna-Ojeda.


Acta Ophthalmologica | 2017

Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye

Juan Carlos Serna-Ojeda; Angel Nava‐Castaneda

To evaluate the efficacy of botulinum toxin type A injection to cause orbicularis eyelid muscle paralysis to improve dry eye signs and symptoms.


Cornea | 2015

Herpes Simplex Virus Disease of the Anterior Segment in Children.

Juan Carlos Serna-Ojeda; Arturo Ramirez-Miranda; Alejandro Navas; Aida Jimenez-Corona; Enrique O Graue-Hernandez

Purpose: To analyze the clinical presentation, characteristics, treatment, recurrences, and final outcomes and complications of herpes simplex virus (HSV) disease of the anterior segment in patients aged 17 years or younger. Methods: This is an observational and retrospective study with review of the medical records of all the children diagnosed with herpes simplex infection of the anterior segment at an ophthalmologic referral center, from 2002 to 2012. The diagnosis was made on the basis of the history and examination of patients and in specific cases by viral culture and the polymerase chain reaction. Main outcome measurements included final visual acuity, bilateral disease, and recurrence. Recurrent disease was analyzed with Kaplan–Meier curves. Results: A total of 103 patients were included with a median age at presentation of 9 years. Of them, 6 had bilateral and simultaneous disease. The median follow-up time was 18 months (range, 18 days–12 years). The most common clinical manifestations were epithelial dendritic keratitis in 42 eyes (38.5%) and interstitial keratitis in 39 eyes (35.7%), with 15 patients presenting multiple forms of HSV disease. The median final visual acuity in the group of patients was 20/40. Recurrent disease was evident in 42 (38.5%) of the eyes, with a median recurrence time of 15 months (95% confidence interval, 8.1–26.2 months). Conclusions: In this study, epithelial dendritic and interstitial keratitis were the most frequent forms of disease in the pediatric population with HSV of the anterior segment. A high rate of recurrent disease was present.


British Journal of Ophthalmology | 2014

Treatment with immunosuppressive therapy in patients with pars planitis: experience of a reference centre in Mexico

Juan Carlos Serna-Ojeda; Miguel Pedroza-Seres

Aim To evaluate the clinical course of the patients with pars planitis that received immunosuppressive drugs. Methods We retrospectively analysed the data of 10 years from 374 patients with pars planitis in a large reference centre in Mexico City and included 49 patients (92 eyes). Results Median age at presentation was 8 years. 35 patients (71.4%) were male and 43 patients (87.7%) had bilateral disease. Diverse immunosuppressive medications were used, mainly methotrexate (69.4%) and azathioprine (63.3%) with 18 patients requiring more than one drug. The main indications for starting immunosuppressive therapy were lack of response to initial treatment and advance disease at presentation. The results showed good response with steroid reduction (69.3% of patients), visual acuity improvement (51% of patients) and inflammatory disease reduction (59.1% of patients). In 25 patients (51%), steroids were started previous to immunosuppressors and in 24 (49%) at the same time without significant difference in clinical improvement (p=0.210) or visual outcome (p=0.498). Thirteen patients (26.5%) presented mild adverse effects. The median of the final visual acuity was 20/40. The median follow-up time was 44 months (range 13–115 months). Conclusions Immunosuppressive therapy allows an adequate control of inflammatory disease in pars planitis, with clinical and visual improvement and steroid dose reduction.


Journal of ophthalmic and vision research | 2016

Intraoperative Flap Complications in LASIK Surgery Performed by Ophthalmology Residents

Lorena Romero-Díaz-de-León; Juan Carlos Serna-Ojeda; Alejandro Navas; Enrique O Graue-Hernandez; Arturo Ramirez-Miranda

Purpose: To report the rate of flap-related complications in LASIK surgery performed by in-training ophthalmology residents and to analyze the risk factors for these complications. Methods: We analyzed 273 flap dissections in 145 patients from March 2013 to February 2014. We included all LASIK surgeries performed by 32 ophthalmology residents using a Moria M2 microkeratome. All the flap-related complications were noted. Comparison between both groups with and without complications was performed with an independent Students t-test and relative risks were calculated. Results: There were 19 flap-related complications out of the 273 flap dissections (6.95%). The most common complication was incomplete flap dissection (n = 10; 3.66%), followed by free-cap (n = 5; 1.83%), and flap-buttonhole (n = 2; 0.73%). There was no significant difference between the complicated and uncomplicated cases in terms of the right versus the left eye, pachymetry results, white-to-white diameter, and spherical equivalent. But this difference was significant for mean keratometry (P = 0.008), K-min (P = 0.01), and K-max (P = 0.03) between these groups. Final visual acuity after rescheduling laser treatment was similar in both groups. Relative risks for flap-related complications were 2.03 for the first LASIK surgery (CI 95% 0.64 to 6.48; P = 0.22) and 1.26 (CI 95% 0.43 to 3.69; P = 0.66) for the surgeons flap-related complications. Female gender presented an odds ratio of 2.48 (CI 95% 0.68 to 9.00; P = 0.16) for complications. Conclusion: Flap-related complications are common intraoperative event during LASIK surgery performed by in-training ophthalmologists. Keratometries and surgeons first procedure represent a higher probability for flap related complications than some other biometric parameters of patients eye.


British Journal of Ophthalmology | 2017

Non-traumatic corneal perforations: aetiology, treatment and outcomes

Denise Loya-Garcia; Juan Carlos Serna-Ojeda; Lucero Pedro-Aguilar; Aida Jimenez-Corona; Andrew Olivo-Payne; Enrique O Graue-Hernandez

Purpose To report aetiology, characteristics, treatment and main outcomes of non-traumatic corneal perforations in a single referral centre. Methods A retrospective review of clinical records of patients diagnosed with non-traumatic corneal perforation. The analysed data included demographic characteristics, medical history, initial and final corrected distance visual acuity (CDVA), perforation aetiology, size, location, initial therapy, surgical treatment, ocular integrity and complications. A comparison between non-infectious and infectious groups was performed. Different variables were analysed through a multiple logistic regression analysis for the probability to have at least one more procedure. Results We included 127 eyes of 116 patients with a mean age of 50 years and a mean follow-up of 11 months. The initial CDVA was 3.00 logarithm of the minimum angle of resolution (logMAR) and the final CDVA was 2.30 logMAR (p>0.5). Regarding treatment, of the 49 eyes with an initial cyanoacrylate patch, 35 eyes (71.4%) had at least one more procedure performed (p>0.001). In comparison, of the 49 eyes with an initial tectonic penetrating keratoplasty (PK), 33 (67.3%) eyes remained stable while 16 (32.7%) eyes needed one or more interventions (p=0.004). In a multiple logistic regression analysis, an initial cyanoacrylate patch represented a probability of 4.7 times to require a subsequent procedure in comparison with an initial PK. Overall, globe integrity was achieved in 96.1% of the cases. Conclusions Corneal perforations represent an important cause of ocular morbidity. The use of a cyanoacrylate patch is useful as an initial therapy in corneal perforations; however, procedures such as PK are often necessary to achieve anatomical success, especially in non-infectious aetiologies.


The Open Ophthalmology Journal | 2016

Characteristics of Sympathetic Ophthalmia in a Single International Center

Pablo Jose Guzman-Salas; Juan Carlos Serna-Ojeda; Ethel Beatriz Guinto-Arcos; Miguel Pedroza-Seres

Aim: To report the main features of sympathetic ophthalmia in a referral ophthalmology center. Methods: Retrospective clinical study. We reviewed clinical records of patients with diagnosis of sympathetic ophthalmia attending the Uveitis Department from 2007 to 2013. Patients were selected by clinical criteria. Descriptive statistics were used to assess variables. Results: Twenty patients were included for analysis, 13 males and 7 females. Mean follow up was 1 year. The median age of presentation was 50 years. Fifty percent had history of ocular trauma and 50% had history of intraocular surgery, of which 40% underwent phacoemulsification. The time between injury and onset of symptoms ranged from 1 to 456 months. Most common ocular manifestations were mutton fat keratic precipitates and anterior chamber inflammation. All patients received oral prednisone as single or combined therapy. Sixty percent of the sympathizing eyes improved two or more lines of vision and 20% lost two or more lines of vision. Conclusion: This report from a single center adds to the body of literature of sympathetic ophthalmia occurring in a specific population. Our data found a high proportion of patients with sympathetic ophthalmia after phacoemulsification.


Clinical and Experimental Ophthalmology | 2017

Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - comment.

Juan Carlos Serna-Ojeda; Enrique O Graue-Hernandez

Significant causes may/may not have localizing symptoms/signs and include stroke (central), apical lung tumour (preganglionic) and ICA dissection (postganglionic). Imaging plays an important role in diagnosing the underlying cause of Horner syndrome, particularly in the absence of localizing features, as in this case. Imaging of the entire sympathetic pathway from the cavernous sinus to the aortic arch at T4–T5 should be considered for any patient who develops an acute Horner syndrome. Given the variability of the path of the secondorder neurons in the sympathetic chain and the close proximity of the aneurysm, it is reasonable to conclude in this case that the aneurysm is responsible for the Horner syndrome as no other cause was found. The standard CTA protocol was able to detect the asymptomatic bronchial artery aneurysm present in our patient. An extensive literature search failed to find a published case of a Horner syndrome caused by a bronchial artery aneurysm.


British Journal of Ophthalmology | 2017

Anterior segment optical coherence tomography angle and vault analysis after toric and non-toric implantable collamer lens V4c implantation in patients with high myopia

Guillermo Garcia-De la Rosa; Andrew Olivo-Payne; Juan Carlos Serna-Ojeda; Maria Sandra Salazar-Ramos; Alejandro Lichtinger; Arturo Gomez-Bastar; Arturo Ramirez-Miranda; Alejandro Navas; Enrique O Graue-Hernandez

Objective To assess anterior segment changes, including iridocorneal angle and vault, after toric and non-toric implantable collamer lens (ICL) V4c (STAAR Surgical AG) implantation under different lighting conditions. Methods Longitudinal, prospective, case series. Patients with high myopia (>6 dioptres) underwent toric and non-toric ICL V4c implantation. Optical coherence tomography measurements were taken under different lighting conditions preoperatively and at 1 week and 1, 6 and 12 months of follow-up. Results Seventy-six eyes of 42 patients underwent ICL V4c implantation. Mean age was 27.4 years (±5.14 years, range 20 to 39 years). The average iridocorneal angle showed a statistically significant decrease (p<0.05) in all mesopic, scotopic and photopic conditions after 1 week of surgery compared with the preoperative measurements; in mesopic conditions, it decreased 14.1°, in photopic conditions 14.8° and scotopic conditions 13.2°. The angle measurement had a statistically significant change only in mesopic conditions (p=0.01) over the 1-year follow-up. The average vault under mesopic conditions was 0.661±0.21 mm at week 1. The vault measurement change was statistically significant over the 1-year follow-up in mesopic conditions (p=0.01). Refractive results showed a significant improvement in both uncorrected and corrected distance visual acuity (p<0.001). Conclusion There is a significant reduction in the iridocorneal angle after ICL V4c implantation. Furthermore, there is a change under mesopic conditions in both the iridocorneal angle and vault during long-term follow-up.


Indian Journal of Ophthalmology | 2016

Interferon alpha-2b in giant ocular surface squamous neoplasia.

Erick Hernandez-Bogantes; Juan Carlos Serna-Ojeda; Alejandro Lichtinger; Enrique O Graue-Hernandez

Interferon alpha-2b has become an ideal topical chemotherapeutic agent to treat selective cases of ocular surface squamous neoplasia (OSSN) due to its efficacy and low toxicity. We present a case series in which interferon alpha-2b achieved primary immunoreduction or immunotherapy in giant OSSN avoiding or minimizing the need of extensive surgery.


Acta Ophthalmologica | 2015

Boston type I Keratoprosthesis assisted with intraprosthetic amniotic membrane (AmniotiKPro sandwich technique)

Alejandro Navas; Julio C. Hernandez-Camarena; Juan Carlos Serna-Ojeda; Arturo Ramirez-Miranda; Enrique O Graue-Hernandez

Costa VP, Arcieri ES & Harris A (2009): Blood pressure and glaucoma. Br J Ophthalmol, 93: 1276–1282. Costa VP, Harris A, Anderson D et al. (2013): Ocular perfusion pressure in glaucoma. Acta Ophthalmol. Published online 18 Nov 2013. doi: 10.1111/aos.12298. [Epub ahead of print]. Khawaja AP, Crabb DP & Jansonius NM (2013): The Role of Ocular Perfusion Pressure in Glaucoma Cannot Be Studied With Multivariable Regression Analysis Applied to Surrogates. Invest Ophthalmol Vis Sci 54: 4619–4620.

Collaboration


Dive into the Juan Carlos Serna-Ojeda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aida Jimenez-Corona

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pablo Jose Guzman-Salas

Universidad de Ciencias Medicas

View shared research outputs
Top Co-Authors

Avatar

Enrique O. Graue-Hernández

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Felipe Soria

University of Montemorelos

View shared research outputs
Researchain Logo
Decentralizing Knowledge